ArticleFrontiers in endocrinology2025
The role of digital health in growth hormone therapy: perspectives from Gulf Cooperation Council pediatric endocrinologists.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: With the increasing use of digital health tools patient-generated health data play a crucial role in clinical decision-making, particularly for monitoring treatment adherence. However, integrating data into routine practice remains challenging, especially for chronic conditions such as growth disorders requiring growth hormone therapy (GHT). Integrating these data is essential to improve treatment adherence and growth outcomes in pediatric patients on GHT. Aim: To explore perspectives of pediatric endocrinologists in the Gulf Cooperation Council (GCC) region on patient-generated health data for improving GHT adherence and identified strategies for integrating such data into clinical practice. Methods: A participatory workshop was conducted on March 2, 2024, in Dubai, United Arab Emirates, using the nominal group technique. Twelve pediatric endocrinologists from the GCC region, one chairman, and two moderators participated in the session. The session centered on three clinical scenarios: GHT naïve (recently diagnosed), poorly adherent, and poor responders. Through two structured voting rounds, experts individually identified, discussed, and ranked the top five most relevant and useful patient-generated health data factors. The first round prioritized key factors, while the second round allowed participants to reassess and refine their selections to reach consensus. The final discussion focused on how identified factors could integrate into clinical practice. Results: Twenty-two influencing factors were identified, representing the most relevant and useful types of patient-generated health data for integration into clinical practice. Top factors in the first ranking round included demographic data (21 points: age, income level, familiarity with technology); patient's feelings about treatments and satisfaction (19 points); and social background (17 points: family support, insurance, caregiving responsibilities). Other considerations included reasons for missed injections and educational needs (15 points each). In the second round, social background (35 points) ranked highest, followed by injection context (34 points: timing, comfort, administration support) and patient's feelings about treatments and satisfaction (30 points) emphasized motivational and emotional aspects of adherence. Conclusion: The study highlights the significant role of social background, injection contexts, and patient satisfaction as key patient-generated health data factors for pediatric endocrinologists in the GCC region. These findings highlight their potential integration into GHT workflows to enhance clinical decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.